Matt Hewitt

Stock Analyst at Craig-Hallum

(2.16)
# 1,260
Out of 4,494 analysts
30
Total ratings
38.71%
Success rate
-0.99%
Average return

13 Stocks

Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135$140
Current: $96.67
Upside: +44.82%
Simulations Plus
Jul 3, 2024
Reiterates: Buy
Price Target: $56
Current: $42.57
Upside: +31.55%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25$10
Current: $2.12
Upside: +371.70%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35$30
Current: $22.69
Upside: +32.22%
Champions Oncology
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.01
Upside: -
Avid Bioservices
Dec 8, 2023
Maintains: Buy
Price Target: $22$16
Current: $8.32
Upside: +92.31%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $4.70
Upside: +48.94%
BioLife Solutions
Aug 10, 2023
Maintains: Buy
Price Target: $29$23
Current: $20.80
Upside: +10.58%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207$200
Current: $122.60
Upside: +63.13%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $4.61
Upside: +116.92%
Teladoc Health
Apr 28, 2022
Maintains: Hold
Price Target: $67$30
Current: $9.26
Upside: +223.97%
iSpecimen
Jan 4, 2022
Initiates: Buy
Price Target: $20
Current: $0.28
Upside: +6,927.41%
Omnicell
Nov 3, 2021
Maintains: Buy
Price Target: n/a
Current: $26.44
Upside: -